Public funding of pharmaceuticals in the Netherlands : investigating the effect of evidence, process and context on CVZ decision-making
Year of publication: |
2014
|
---|---|
Authors: | Cerri, Karin H. ; Knapp, Martin ; Fernández, José-Luis |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 15.2014, 7, p. 681-695
|
Subject: | Health technology assessment | HTA | CVZ | Payer decision-making | Reimbursement | Coverage | Pharmaceuticals | Appraisal | Dutch reimbursement | Niederlande | Netherlands | Arzneimittel | Pharmaindustrie | Pharmaceutical industry | Entscheidung | Decision | Gesundheitskosten | Health care costs | Gesundheitswesen | Health care system | Medizintechnik | Medical technology | Technikfolgenabschätzung | Technology assessment |
-
Cerri, Karin, (2014)
-
Consideration of quality of life in the health technology assessments of rare disease treatments
Nicod, Elena, (2022)
-
Reimbursement of pharmaceuticals : reference pricing versus health technology assessment
Drummond, Michael F., (2011)
- More ...
-
Decision making by NICE: examining the influences of evidence, process and context
Cerri, Karin H., (2014)
-
Henderson, Catherine, (2013)
-
Knapp, Martin, (2015)
- More ...